$165.67 +1.48 (0.90%) Amgen Inc - NASDAQ

Jul. 22, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 165.67
Trade Time: Jul 22 04:00 PM Eastern Daylight Time
Change: +1.48 (0.90%)
Prev Close: 164.19
Open: 164.78
Bid: 165.62
Ask: 165.67
  1. Week In Review: Stock Breakouts, Netflix Subs Snub, Tesla's Plan, M&A News

    Investors Business Daily | Jul. 22, 2016 | 12:25PM EST
  2. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 10:44AM EST
  3. Chardan Upgrades Regeneron Amid Relative Underperformance To Amgen Shares

    Benzinga | Feb. 16, 2016 | 08:33AM EST
  4. Gilead, Johnson & Johnson or Roche?

    GuruFocus | Feb. 11, 2016 | 12:15PM EST
  5. Amgen, Celgene Buck Short Interest Trend In Biotech Stocks

    Benzinga | Feb. 11, 2016 | 07:49AM EST
  6. Chardan: Sell Regeneron After Sanofi Drops Patent Infringement Bombshell

    Benzinga | Feb. 10, 2016 | 09:30AM EST
  7. The Generic Drug Battle

    Benzinga | Feb. 10, 2016 | 09:13AM EST
  8. Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch

    IBD | Feb. 9, 2016 | 11:28AM EST
  9. Schoenebaum: Biotech P/Es Show 'Buying Signal' With Caveat; Amgen, Biogen, Celgene & Gilead Have Catalysts

    Benzinga | Feb. 8, 2016 | 15:27PM EST
  10. Pharmaceuticals Turn To Politics To Protect Prices

    Benzinga | Feb. 8, 2016 | 08:17AM EST
  11. Leerink Is Back On Board The Biotech Train

    Benzinga | Feb. 5, 2016 | 10:32AM EST
  12. LinkedIn Downgraded; Biotechs Initiated; Tableau PT Cut

    IBD | Feb. 5, 2016 | 09:16AM EST
  13. Plenty of Opportunity to Buy Individual Stocks: John Buckingham

    GuruFocus | Feb. 2, 2016 | 12:32PM EST
  14. Maybe Some Good News For A Big Biotech ETF

    Benzinga | Jan. 29, 2016 | 08:39AM EST
  15. Why Amazon, Microsoft, Xerox And Amgen Are Moving After-Hours

    Benzinga | Jan. 28, 2016 | 16:52PM EST
Trading Center